Intermediate-dose prophylactic anticoagulation with low molecular weight heparin is safe after bioprosthetic artificial heart implantation
David M. Smadja, Peter Ivák, Yuri Pya, Christian Latrémouille, Finn Gustafsson, Jean‐Christian Roussel, André Vincentelli, Erwan Flécher, Piet Jansen, Ivan Netuka
Topics & Concepts
Artificial heartMedicineHeart failureWarfarinVitamin K antagonistLow molecular weight heparinCardiologyAntithromboticHeparinVentricular assist deviceInternal medicineHeart transplantationAspirinAtrial fibrillationMechanical Circulatory Support DevicesCardiac Structural Anomalies and RepairTransplantation: Methods and Outcomes